ICLR Competitors & Alternatives
Compare ICON PLC with similar stocks in the same industry
Diagnostics & Research
ICLR
Main Stock$173.06
Tradestie Score
51
Market Cap
$14.96B
P/E Ratio
76.8
Revenue Growth
0.0%
Analyst Upside
+3.0%
Top Competitors
36 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DGX
Quest Diagnostics Inc.
|
$215.72
|
$20.36B | 23.9 | 61 | Compare |
|
WST
West Pharmaceutical Services, Inc.
|
$365.74
|
$19.52B | 48.8 | 64 | Compare |
|
WAT
Waters Corp
|
$379.29
|
$19.04B | 48.0 | 59 | Compare |
|
ILMN
Illumina Inc
|
$188.68
|
$15.72B | 33.4 | 59 | Compare |
|
MEDP
Medpace Holdings, Inc. Common Stock
|
$557.60
|
$15.28B | 34.3 | 58 | Compare |
|
EXAS
Exact Sciences Corp
|
$104.91
|
$10.68B | - | 65 | Compare |
|
RVTY
Revvity, Inc.
|
$113.76
|
$10.65B | 54.3 | 61 | Compare |
|
QGEN
QIAGEN N.V.
|
$40.10
|
$10.04B | 20.0 | 60 | Compare |
|
CRL
Charles River Laboratories International, Inc.
|
$230.69
|
$8.39B | - | 60 | Compare |
|
GH
Guardant Health, Inc. Common Stock
|
$167.98
|
$7.81B | - | 61 | Compare |
More ICLR Analysis
Data updated: Jul 04, 2026 | Industry: Diagnostics & Research (SIC 8731)
36 stocks in this industry